Expert Opinion on Drug Delivery
Volume 21, 2024 - Issue 5
Original Research
Compared implementation of the long-acting buprenorphine treatment buvidal in four European countries
Benjamin Rollanda Service Universitaire d’Addictologie de Lyon (SUAL), Hospices Civils de Lyon, CH Le Vinatier, Lyon, FranceCorrespondence[email protected]
https://orcid.org/0000-0002-8666-3635View further author information
https://orcid.org/0000-0002-8666-3635View further author information, Catriona Mathesonb Faculty of Social Sciences, Colin Bell Building, University of Stirling, Stirling, UKhttps://orcid.org/0000-0002-7568-1125View further author information
https://orcid.org/0000-0002-7568-1125View further author information, , Margaux Kosimd Camurus SAS, Paris, France;e Assistance Publique- Hôpitaux de Paris, GHU Sorbonne Université, Hôpital Pitié-Salpêtrière, Consultations de médecine-Alcoologie PASS, Paris, Francehttps://orcid.org/0000-0002-9874-8978View further author information
https://orcid.org/0000-0002-9874-8978View further author information, Carlos Roncerof Unidad de Psiquiatría, Facultad de Medicinia, Universidad de Salamanca & Instituto de Biomedicina (IBSAL), Spain; Universidad de Salamanca, C, Salamanca, Spainhttps://orcid.org/0009-0004-1829-1456View further author information
https://orcid.org/0009-0004-1829-1456View further author information & Florence Vorspang Université Paris Cité, UFR de Médecine et INSERM UMRS 1144, Paris, France; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, GHU NORD, Assistance Publique - Hôpitaux de, Paris, Francehttps://orcid.org/0000-0001-5168-3727View further author information
https://orcid.org/0000-0001-5168-3727View further author information